Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Novolin 70/30 [package insert]. Princeton, NJ: Novo Nordisk, Inc.;2013 March.
Novo Nordisk. Dear healthcare provider letter: important insulin delivery device information: discontinuation of several insulin delivery devices (June 2009). FDA Web site. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM177158.pdf. Accessed August 21, 2009.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click